Thomas Vercruysse

Haasrode, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates.

Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primates.

Journal: Nature communications
Published: October 10, 2024

Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Journal: Communications biology
Published: May 08, 2024

3-nitropyridine analogues as novel microtubule-targeting agents.

3-nitropyridine analogues as novel microtubule-targeting agents.

Journal: PloS one
Published: January 30, 2024

Multiplexed multicolor antiviral assay amenable for high-throughput research.

Multiplexed multicolor antiviral assay amenable for high-throughput research.

Journal: Nature communications
Published: February 09, 2023

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge.

Journal: NPJ vaccines
Published: January 13, 2023

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.

Journal: Cell
Published: November 14, 2022

A High-Throughput Yellow Fever Neutralization Assay.

A High-Throughput Yellow Fever Neutralization Assay.

Journal: Microbiology spectrum
Published: June 07, 2022

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.

Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.

Journal: EBioMedicine
Published: May 23, 2022

High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.

High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium.

Journal: Viruses
Published: May 10, 2022

Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules.

Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules.

Journal: Biomedicines
Published: March 31, 2022

Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters.

Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters.

Journal: Nature communications
Published: March 22, 2022

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.

Journal: Frontiers in immunology
Published: December 30, 2021
Showing 1-12 of 32

Last Updated: 09/26/2026